In line with increased infiltration of cluster #2 cancers by T cells, clinically relevant immune checkpoint genes CTLA4, TIGIT, and PDCD1 were found to be expressed in this cluster at the highest levels (Supplementary Figure S9). This evidence concerns the gene TIGIT and cancer.